$127 Million is the total value of Privium Fund Management (UK) Ltd's 65 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMZN | AMAZON COM INC | $5,008,200 | +21.2% | 49,100 | 0.0% | 3.94% | +25.8% | |
| MSFT | MICROSOFT CORP | $2,767,783 | +17.9% | 9,744 | 0.0% | 2.18% | +22.3% | |
| MCHI | ISHARES TRmsci china etf | $2,663,036 | +4.1% | 52,859 | 0.0% | 2.10% | +8.1% | |
| XLB | SELECT SECTOR SPDR TRsbi materials | $2,063,144 | +1.5% | 25,994 | 0.0% | 1.62% | +5.3% | |
| EWH | ISHARES INCmsci hong kg etf | $2,058,371 | -3.2% | 99,679 | 0.0% | 1.62% | +0.5% | |
| EWC | ISHARES INCmsci cda etf | $1,894,163 | +2.7% | 55,908 | 0.0% | 1.49% | +6.6% | |
| EWY | ISHARES INCmsci sth kor etf | $1,686,904 | +6.2% | 27,800 | 0.0% | 1.33% | +10.3% | |
| IYR | ISHARES TRu.s. real es etf | $1,661,586 | -2.0% | 19,983 | 0.0% | 1.31% | +1.7% | |
| FXO | FIRST TR EXCHANGE TRADED FDfinls alphadex | $1,605,011 | -10.7% | 43,650 | 0.0% | 1.26% | -7.3% | |
| ARB | ALTSHARES TRUSTmerger arbitrage | $1,592,534 | -1.7% | 62,900 | 0.0% | 1.26% | +2.0% | |
| EWZ | ISHARES INCmsci brazil etf | $1,561,805 | -1.7% | 56,444 | 0.0% | 1.23% | +2.0% | |
| XLU | SELECT SECTOR SPDR TRsbi int-utils | $1,505,280 | -5.6% | 22,400 | 0.0% | 1.19% | -2.0% | |
| XBI | SPDR SER TRs&p biotech | $1,403,049 | -9.2% | 18,790 | 0.0% | 1.10% | -5.8% | |
| PYPL | PAYPAL HLDGS INC | $1,167,625 | +5.4% | 15,696 | 0.0% | 0.92% | +9.4% | |
| XLY | SELECT SECTOR SPDR TRsbi cons discr | $920,799 | +12.5% | 6,322 | 0.0% | 0.72% | +16.7% | |
| EWT | ISHARES INCmsci taiwan etf | $881,519 | +11.5% | 19,451 | 0.0% | 0.69% | +15.7% | |
| TARA | PROTARA THERAPEUTICS INC | $401,096 | +25.0% | 119,730 | 0.0% | 0.32% | +29.5% | |
| ALGOMA STL GROUP INC | $199,896 | +22.6% | 19,074 | 0.0% | 0.16% | +26.6% | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $150,306 | -0.8% | 116,516 | 0.0% | 0.12% | +2.6% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $131,128 | -1.3% | 177,200 | 0.0% | 0.10% | +2.0% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $80,270 | +34.6% | 117,200 | 0.0% | 0.06% | +40.0% | |
| TSCAN THERAPEUTICS INC | $40,987 | +67.1% | 15,825 | 0.0% | 0.03% | +68.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-03
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALASKA AIR GROUP INC | 11 | Q3 2023 | 2.6% |
| CONTROLADORA VUELA COMP DE A | 11 | Q3 2023 | 1.7% |
| ALPHABET INC | 10 | Q3 2023 | 10.1% |
| COPA HOLDINGS SA | 9 | Q3 2023 | 1.8% |
| DELTA AIR LINES INC DEL | 8 | Q3 2023 | 2.7% |
| SPDR GOLD TR | 8 | Q4 2022 | 1.6% |
| ACELRX PHARMACEUTICALS INC | 8 | Q3 2022 | 0.0% |
| ISHARES INC | 7 | Q3 2023 | 5.4% |
| TECK RESOURCES LTD | 7 | Q3 2022 | 1.9% |
| ISHARES TR | 7 | Q3 2023 | 2.1% |
View Privium Fund Management (UK) Ltd's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-29 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-07-26 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-09 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-05-10 |
| 13F-HR/A | 2022-03-25 |
View Privium Fund Management (UK) Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.